Watch for Zelnorm's Return for Irritable Bowel Syndrome With Constipation

October 2019

Zelnorm (tegaserod) will be back on the market to treat irritable bowel syndrome with constipation (IBS-C) in women.

It was first approved in 2002...then taken off the market in 2007 due to reports of MI, stroke, and unstable angina.

Since then, it's been available on a case-by-case basis from various manufacturers.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote